img

Global Lanreotide Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lanreotide Market Research Report 2024

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
According to Mr Accuracy reports new survey, global Lanreotide market is projected to reach US$ 1506.5 million in 2029, increasing from US$ 1401 million in 2022, with the CAGR of 1.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lanreotide market research.
Lanreotide is a somatostatin analog primarily used to treat acromegaly and neuroendocrine tumors. Its efficacy in controlling hormone secretion and tumor growth has driven market growth. The rising prevalence of acromegaly and neuroendocrine tumors, coupled with the drug's extended duration of action, contributes to its popularity. However, competition from other somatostatin analogs and the need for individualized treatment plans may pose challenges. The market is relatively small compared to other therapeutic areas. Despite challenges, the Lanreotide market presents potential for expansion as healthcare providers prioritize personalized and targeted therapies for acromegaly and neuroendocrine tumors, creating opportunities for further development and investment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lanreotide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


IPSEN
Segment by Type
60 mg
90 mg
120 mg

Segment by Application


Hospital
Pharmacy

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Lanreotide report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Lanreotide Market Overview
1.1 Product Overview and Scope of Lanreotide
1.2 Lanreotide Segment by Type
1.2.1 Global Lanreotide Market Value Comparison by Type (2024-2034)
1.2.2 60 mg
1.2.3 90 mg
1.2.4 120 mg
1.3 Lanreotide Segment by Application
1.3.1 Global Lanreotide Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Lanreotide Market Size Estimates and Forecasts
1.4.1 Global Lanreotide Revenue 2018-2029
1.4.2 Global Lanreotide Sales 2018-2029
1.4.3 Global Lanreotide Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Lanreotide Market Competition by Manufacturers
2.1 Global Lanreotide Sales Market Share by Manufacturers (2018-2024)
2.2 Global Lanreotide Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Lanreotide Average Price by Manufacturers (2018-2024)
2.4 Global Lanreotide Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Lanreotide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lanreotide, Product Type & Application
2.7 Lanreotide Market Competitive Situation and Trends
2.7.1 Lanreotide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lanreotide Players Market Share by Revenue
2.7.3 Global Lanreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lanreotide Retrospective Market Scenario by Region
3.1 Global Lanreotide Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Lanreotide Global Lanreotide Sales by Region: 2018-2029
3.2.1 Global Lanreotide Sales by Region: 2018-2024
3.2.2 Global Lanreotide Sales by Region: 2024-2029
3.3 Global Lanreotide Global Lanreotide Revenue by Region: 2018-2029
3.3.1 Global Lanreotide Revenue by Region: 2018-2024
3.3.2 Global Lanreotide Revenue by Region: 2024-2029
3.4 North America Lanreotide Market Facts & Figures by Country
3.4.1 North America Lanreotide Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Lanreotide Sales by Country (2018-2029)
3.4.3 North America Lanreotide Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Lanreotide Market Facts & Figures by Country
3.5.1 Europe Lanreotide Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Lanreotide Sales by Country (2018-2029)
3.5.3 Europe Lanreotide Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lanreotide Market Facts & Figures by Country
3.6.1 Asia Pacific Lanreotide Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Lanreotide Sales by Country (2018-2029)
3.6.3 Asia Pacific Lanreotide Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lanreotide Market Facts & Figures by Country
3.7.1 Latin America Lanreotide Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Lanreotide Sales by Country (2018-2029)
3.7.3 Latin America Lanreotide Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lanreotide Market Facts & Figures by Country
3.8.1 Middle East and Africa Lanreotide Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Lanreotide Sales by Country (2018-2029)
3.8.3 Middle East and Africa Lanreotide Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lanreotide Sales by Type (2018-2029)
4.1.1 Global Lanreotide Sales by Type (2018-2024)
4.1.2 Global Lanreotide Sales by Type (2024-2029)
4.1.3 Global Lanreotide Sales Market Share by Type (2018-2029)
4.2 Global Lanreotide Revenue by Type (2018-2029)
4.2.1 Global Lanreotide Revenue by Type (2018-2024)
4.2.2 Global Lanreotide Revenue by Type (2024-2029)
4.2.3 Global Lanreotide Revenue Market Share by Type (2018-2029)
4.3 Global Lanreotide Price by Type (2018-2029)
5 Segment by Application
5.1 Global Lanreotide Sales by Application (2018-2029)
5.1.1 Global Lanreotide Sales by Application (2018-2024)
5.1.2 Global Lanreotide Sales by Application (2024-2029)
5.1.3 Global Lanreotide Sales Market Share by Application (2018-2029)
5.2 Global Lanreotide Revenue by Application (2018-2029)
5.2.1 Global Lanreotide Revenue by Application (2018-2024)
5.2.2 Global Lanreotide Revenue by Application (2024-2029)
5.2.3 Global Lanreotide Revenue Market Share by Application (2018-2029)
5.3 Global Lanreotide Price by Application (2018-2029)
6 Key Companies Profiled
6.1 IPSEN
6.1.1 IPSEN Corporation Information
6.1.2 IPSEN Description and Business Overview
6.1.3 IPSEN Lanreotide Sales, Revenue and Gross Margin (2018-2024)
6.1.4 IPSEN Lanreotide Product Portfolio
6.1.5 IPSEN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lanreotide Industry Chain Analysis
7.2 Lanreotide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lanreotide Production Mode & Process
7.4 Lanreotide Sales and Marketing
7.4.1 Lanreotide Sales Channels
7.4.2 Lanreotide Distributors
7.5 Lanreotide Customers
8 Lanreotide Market Dynamics
8.1 Lanreotide Industry Trends
8.2 Lanreotide Market Drivers
8.3 Lanreotide Market Challenges
8.4 Lanreotide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Lanreotide Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Lanreotide Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Lanreotide Market Competitive Situation by Manufacturers in 2022
Table 4. Global Lanreotide Sales (Units) of Key Manufacturers (2018-2024)
Table 5. Global Lanreotide Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Lanreotide Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Lanreotide Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Lanreotide Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Lanreotide, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Lanreotide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lanreotide, Product Type & Application
Table 12. Global Key Manufacturers of Lanreotide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lanreotide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lanreotide as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lanreotide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Lanreotide Sales by Region (2018-2024) & (Units)
Table 18. Global Lanreotide Sales Market Share by Region (2018-2024)
Table 19. Global Lanreotide Sales by Region (2024-2029) & (Units)
Table 20. Global Lanreotide Sales Market Share by Region (2024-2029)
Table 21. Global Lanreotide Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Lanreotide Revenue Market Share by Region (2018-2024)
Table 23. Global Lanreotide Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Lanreotide Revenue Market Share by Region (2024-2029)
Table 25. North America Lanreotide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Lanreotide Sales by Country (2018-2024) & (Units)
Table 27. North America Lanreotide Sales by Country (2024-2029) & (Units)
Table 28. North America Lanreotide Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Lanreotide Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Lanreotide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Lanreotide Sales by Country (2018-2024) & (Units)
Table 32. Europe Lanreotide Sales by Country (2024-2029) & (Units)
Table 33. Europe Lanreotide Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Lanreotide Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Lanreotide Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Lanreotide Sales by Region (2018-2024) & (Units)
Table 37. Asia Pacific Lanreotide Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Lanreotide Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Lanreotide Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Lanreotide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Lanreotide Sales by Country (2018-2024) & (Units)
Table 42. Latin America Lanreotide Sales by Country (2024-2029) & (Units)
Table 43. Latin America Lanreotide Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Lanreotide Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Lanreotide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Lanreotide Sales by Country (2018-2024) & (Units)
Table 47. Middle East & Africa Lanreotide Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Lanreotide Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Lanreotide Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Lanreotide Sales (Units) by Type (2018-2024)
Table 51. Global Lanreotide Sales (Units) by Type (2024-2029)
Table 52. Global Lanreotide Sales Market Share by Type (2018-2024)
Table 53. Global Lanreotide Sales Market Share by Type (2024-2029)
Table 54. Global Lanreotide Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Lanreotide Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Lanreotide Revenue Market Share by Type (2018-2024)
Table 57. Global Lanreotide Revenue Market Share by Type (2024-2029)
Table 58. Global Lanreotide Price (USD/Unit) by Type (2018-2024)
Table 59. Global Lanreotide Price (USD/Unit) by Type (2024-2029)
Table 60. Global Lanreotide Sales (Units) by Application (2018-2024)
Table 61. Global Lanreotide Sales (Units) by Application (2024-2029)
Table 62. Global Lanreotide Sales Market Share by Application (2018-2024)
Table 63. Global Lanreotide Sales Market Share by Application (2024-2029)
Table 64. Global Lanreotide Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Lanreotide Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Lanreotide Revenue Market Share by Application (2018-2024)
Table 67. Global Lanreotide Revenue Market Share by Application (2024-2029)
Table 68. Global Lanreotide Price (USD/Unit) by Application (2018-2024)
Table 69. Global Lanreotide Price (USD/Unit) by Application (2024-2029)
Table 70. IPSEN Corporation Information
Table 71. IPSEN Description and Business Overview
Table 72. IPSEN Lanreotide Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. IPSEN Lanreotide Product
Table 74. IPSEN Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Lanreotide Distributors List
Table 78. Lanreotide Customers List
Table 79. Lanreotide Market Trends
Table 80. Lanreotide Market Drivers
Table 81. Lanreotide Market Challenges
Table 82. Lanreotide Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lanreotide
Figure 2. Global Lanreotide Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Lanreotide Market Share by Type in 2022 & 2029
Figure 4. 60 mg Product Picture
Figure 5. 90 mg Product Picture
Figure 6. 120 mg Product Picture
Figure 7. Global Lanreotide Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Lanreotide Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Global Lanreotide Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Lanreotide Market Size (2018-2029) & (US$ Million)
Figure 13. Global Lanreotide Sales (2018-2029) & (Units)
Figure 14. Global Lanreotide Average Price (USD/Unit) & (2018-2029)
Figure 15. Lanreotide Report Years Considered
Figure 16. Lanreotide Sales Share by Manufacturers in 2022
Figure 17. Global Lanreotide Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Lanreotide Players: Market Share by Revenue in 2022
Figure 19. Lanreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Lanreotide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Lanreotide Sales Market Share by Country (2018-2029)
Figure 22. North America Lanreotide Revenue Market Share by Country (2018-2029)
Figure 23. the United States Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Lanreotide Sales Market Share by Country (2018-2029)
Figure 26. Europe Lanreotide Revenue Market Share by Country (2018-2029)
Figure 27. Germany Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. UK Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Lanreotide Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Lanreotide Revenue Market Share by Region (2018-2029)
Figure 34. China Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Lanreotide Sales Market Share by Country (2018-2029)
Figure 44. Latin America Lanreotide Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Lanreotide Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Lanreotide Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Lanreotide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Lanreotide by Type (2018-2029)
Figure 54. Global Revenue Market Share of Lanreotide by Type (2018-2029)
Figure 55. Global Lanreotide Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Lanreotide by Application (2018-2029)
Figure 57. Global Revenue Market Share of Lanreotide by Application (2018-2029)
Figure 58. Global Lanreotide Price (USD/Unit) by Application (2018-2029)
Figure 59. Lanreotide Value Chain
Figure 60. Lanreotide Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed